Private Placement

Merck's breakthrough PAH drug is now covered in several provinces, offering new hope. But what about its high cost and access for the rest of Canada?

With a cash runway into 2027, the biotech firm prepares for critical data on its innovative bispecific antibody pipeline for hard-to-treat solid tumors.

A delegation of Taiwanese startups at NVIDIA's GTC 2026 signals a strategic national shift from hardware maker to a global leader in AI software and services.

Wilmington PharmaTech is doubling its API capacity, a key move to bolster the U.S. drug supply chain and reduce reliance on foreign manufacturing.

As data centers and AI fuel a historic surge in power demand, Red Post Energy hires a key government veteran to navigate the U.S. infrastructure race.

A new advisory model lets high-earners redirect tax liabilities into the growing EV charging market, leveraging federal incentives before they expire.

Splitit's new mobile solution lets contractors and doctors offer installments on existing credit cards, targeting a $4.6 trillion face-to-face market.

With a new $40M loan, Hyperfine is set to accelerate the rollout of its Swoop® system, bringing AI-powered brain imaging directly to the patient's bedside.

Tempest Therapeutics raises up to $6M in a critical financing deal to advance its CAR-T pipeline, balancing promising clinical data with financial pressures.

With the appointment of Ben Wright as CRO, Insight Assurance signals a major push for global growth, leveraging AI to tackle complex cybersecurity regulations.

A new partnership between Basys.ai and ePathUSA will use 'agentic AI' to overhaul medical record review, aiming to curb waste and improve efficiency.

A new R&D center in Singapore is using AI to build atomic-scale machines, tackling the critical hardware bottleneck for the next generation of AI.

The company's first full year in logistics shows massive revenue growth, yet widening losses and an asset write-down raise questions about its path forward.

With a $4M boost from the Air Force and private capital, Luminous Cyber is fast-tracking its GPS-free navigation tech for defense and industry.

DMZ's summit channels $210,000 to women-led startups, signaling a strategic push into Canada’s critical AI, defence, and cybersecurity sectors.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

A new AI-powered platform, Satcat Terminal, is giving investors and insurers unprecedented, real-time intelligence on satellite assets orbiting Earth.

A new development in Miami Gardens partners Italian luxury design with advanced tech, promising equitable housing. But can it deliver on its lofty goals?

A new book by a top physician-scientist challenges the idea that innovation comes from the private sector, arguing Medicaid is a lab for bold experiments.